UNLABELLED: In type 2 diabetes (T2D), insulin resistance is related to comorbidities, including high lipotoxicity, poor glucoregulation, and loss of metabolic flexibility. Controversy exists regarding whether reduced metabolic flexibility precedes insulin resistance or vice versa. PURPOSE: The purpose of this study was to determine whether a family history of T2D leads to metabolic inflexibility. METHODS: To examine potential loss of metabolic flexibility at early stages, we used a hooded metabolic cart to compare metabolic characteristics in people with T2D, family history of T2D (FH+), and controls (FH-) 1) at rest, 2) with passive stretching (PS) and recovery, and 3) with oral glucose load. Testing of 9 T2D, 11 FH+, and 9 FH- occurred after a 12-h fast under resting conditions. Expired gas and blood glucose (BG) were measured before and after each condition. RESULTS: PS lowered BG (P < 0.05) in FH- and FH+ (mean ± SD, -2.7 ± 5.9 and -5.8 ± 7.5 mg·mL(-1)) compared with T2D (-0.9 ± 7.7). CHO use (kcal·min(-1)) increased with PS in all groups (0.04 ± 0.18, 0.03 ± 0.26, and 0.22 ± 1.6 mg·mL(-1) in FH-, FH+, and T2D, respectively). For oral glucose load, different metabolic flexibility existed between FH- as well as FH+ (0.16 ± 0.07) as well as T2D (0.16 ± 0.07), with no difference between FH- and T2D. CONCLUSION: PS increases glycolytic activity without affecting BG in T2D, and reductions in metabolic flexibility exist in T2D and FH+ without glucoregulatory impairment in FH+, indicating early stage of mitochondrial dysfunction in FH+. Findings indicate PS is an important tool for assessing metabolic flexibility.
UNLABELLED: In type 2 diabetes (T2D), insulin resistance is related to comorbidities, including high lipotoxicity, poor glucoregulation, and loss of metabolic flexibility. Controversy exists regarding whether reduced metabolic flexibility precedes insulin resistance or vice versa. PURPOSE: The purpose of this study was to determine whether a family history of T2D leads to metabolic inflexibility. METHODS: To examine potential loss of metabolic flexibility at early stages, we used a hooded metabolic cart to compare metabolic characteristics in people with T2D, family history of T2D (FH+), and controls (FH-) 1) at rest, 2) with passive stretching (PS) and recovery, and 3) with oral glucose load. Testing of 9 T2D, 11 FH+, and 9 FH- occurred after a 12-h fast under resting conditions. Expired gas and blood glucose (BG) were measured before and after each condition. RESULTS: PS lowered BG (P < 0.05) in FH- and FH+ (mean ± SD, -2.7 ± 5.9 and -5.8 ± 7.5 mg·mL(-1)) compared with T2D (-0.9 ± 7.7). CHO use (kcal·min(-1)) increased with PS in all groups (0.04 ± 0.18, 0.03 ± 0.26, and 0.22 ± 1.6 mg·mL(-1) in FH-, FH+, and T2D, respectively). For oral glucose load, different metabolic flexibility existed between FH- as well as FH+ (0.16 ± 0.07) as well as T2D (0.16 ± 0.07), with no difference between FH- and T2D. CONCLUSION: PS increases glycolytic activity without affecting BG in T2D, and reductions in metabolic flexibility exist in T2D and FH+ without glucoregulatory impairment in FH+, indicating early stage of mitochondrial dysfunction in FH+. Findings indicate PS is an important tool for assessing metabolic flexibility.
Authors: Ryan D Russell; Katherine M Roberts-Thomson; Donghua Hu; Timothy Greenaway; Andrew C Betik; Lewan Parker; James E Sharman; Stephen M Richards; Stephen Rattigan; Dino Premilovac; Glenn D Wadley; Michelle A Keske Journal: Diabetologia Date: 2021-09-29 Impact factor: 10.122
Authors: C Ekman; T Elgzyri; K Ström; P Almgren; H Parikh; Marloes Dekker Nitert; T Rönn; Fiona Manderson Koivula; C Ling; Å B Tornberg; P Wollmer; K F Eriksson; L Groop; O Hansson Journal: J Appl Physiol (1985) Date: 2015-09-03
Authors: Sarah Keildson; Joao Fadista; Claes Ladenvall; Åsa K Hedman; Targ Elgzyri; Kerrin S Small; Elin Grundberg; Alexandra C Nica; Daniel Glass; J Brent Richards; Amy Barrett; James Nisbet; Hou-Feng Zheng; Tina Rönn; Kristoffer Ström; Karl-Fredrik Eriksson; Inga Prokopenko; Timothy D Spector; Emmanouil T Dermitzakis; Panos Deloukas; Mark I McCarthy; Johan Rung; Leif Groop; Paul W Franks; Cecilia M Lindgren; Ola Hansson Journal: Diabetes Date: 2013-12-04 Impact factor: 9.461
Authors: Timothy D Allerton; Brian A Irving; Guillaume Spielmann; Stefany Primeaux; Dennis Landin; Arnold Nelson; Neil M Johannsen Journal: Physiol Rep Date: 2019-09